The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


The Annals of Pharmacotherapy: Vol. 34, No. 9, pp. 1013-1016. DOI 10.1345/aph.10088
© 2000 Harvey Whitney Books Company.
This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barone, G.
Right arrow Articles by Abul-Ezz, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barone, G.
Right arrow Articles by Abul-Ezz, S.


Research Articles

Drug interaction between St. John's wort and cyclosporine

GW Barone, BJ Gurley, BL Ketel, ML Lightfoot, and SR Abul-Ezz

OBJECTIVE: To report a probable drug interaction between the herbal dietary supplement St. John's wort and cyclosporine. CASE REPORT: A 29-year-old white woman who received a cadaveric kidney and pancreas transplant, with stable organ function and stable cyclosporine concentrations began self-medicating with St. John's wort. After taking St. John's wort supplements for four to eight weeks, her cyclosporine concentrations became subtherapeutic; this was associated with organ rejection. Four weeks after stopping St. John's wort, her cyclosporine concentrations again became therapeutic. Subsequent to this rejection episode, she has developed chronic rejection and now has returned to dialysis. DISCUSSION: St. John's wort is suspected to be a significant inducer of CYP3A4 isoenzyme activity and of P-glycoprotein (P-gp) expression, both of which are important in the metabolism and absorption of cyclosporine. Cyclosporine exhibits a relatively small therapeutic window and is sensitive to medications that can modulate the CYP3A4 isoenzyme and P-gp in both the liver and small intestines. CONCLUSIONS: Patients taking St. John's wort concomitant with other prescription medications whose absorption and metabolism are mediated by the CYP3A4 isoenzyme and P-gp require close monitoring. Patient medication histories should include inquiries into the use of herbal dietary supplements.


This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
E. G. van de Kerkhof, I. A. M. de Graaf, M. H. de Jager, and G. M. M. Groothuis
Induction of Phase I and II Drug Metabolism in Rat Small Intestine and Colon in Vitro
Drug Metab. Dispos., June 1, 2007; 35(6): 898 - 907.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
J. Boullata
Natural Health Product Interactions with Medication
Nutr Clin Pract, February 1, 2005; 20(1): 33 - 51.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
H. Iwata, Y. Tezuka, S. Kadota, A. Hiratsuka, and T. Watabe
IDENTIFICATION AND CHARACTERIZATION OF POTENT CYP3A4 INHIBITORS IN SCHISANDRA FRUIT EXTRACT
Drug Metab. Dispos., December 1, 2004; 32(12): 1351 - 1358.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. Sparreboom, M. C. Cox, M. R. Acharya, and W. D. Figg
Herbal Remedies in the United States: Potential Adverse Interactions With Anticancer Agents
J. Clin. Oncol., June 15, 2004; 22(12): 2489 - 2503.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
S. Zhou, E. Chan, S.-Q. Pan, M. Huang, and E. J. D. Lee
Pharmacokinetic Interactions of Drugs with St John's Wort
J Psychopharmacol, June 1, 2004; 18(2): 262 - 276.
[Abstract] [PDF]


Home page
J Clin PharmacolHome page
L.-S. Wang, B. Zhu, A. M. A. El-Aty, G. Zhou, Z. Li, J. Wu, G.-L. Chen, J. Liu, Z. R. Tang, W. An, et al.
The Influence of St. John's Wort on CYP2C19 Activity with Respect to Genotype
J. Clin. Pharmacol., June 1, 2004; 44(6): 577 - 581.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. A. Navo, J. Phan, C. Vaughan, J. L. Palmer, L. Michaud, K. L. Jones, D. C. Bodurka, K. Basen-Engquist, G. N. Hortobagyi, J. J. Kavanagh, et al.
An Assessment of the Utilization of Complementary and Alternative Medication in Women With Gynecologic or Breast Malignancies
J. Clin. Oncol., February 15, 2004; 22(4): 671 - 677.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
Y. Cui, C. Y.W. Ang, R. D. Beger, T. M. Heinze, L. Hu, and J. Leakey
IN VITRO METABOLISM OF HYPERFORIN IN RAT LIVER MICROSOMAL SYSTEMS
Drug Metab. Dispos., January 1, 2004; 32(1): 28 - 34.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
M. F. Hebert, J. M. Park, Y.-L. Chen, S. Akhtar, and A. M. Larson
Effects of St. John's Wort (Hypericum perforatum) on Tacrolimus Pharmacokinetics in Healthy Volunteers
J. Clin. Pharmacol., January 1, 2004; 44(1): 89 - 94.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. Mizuno, T. Niwa, Y. Yotsumoto, and Y. Sugiyama
Impact of Drug Transporter Studies on Drug Discovery and Development
Pharmacol. Rev., September 1, 2003; 55(3): 425 - 461.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
K. I. Block and C. Gyllenhaal
Clinical Corner: Herb-Drug Interactions in Cancer Chemotherapy: Theoretical Concerns Regarding Drug Metabolizing Enzymes
Integr Cancer Ther, March 1, 2002; 1(1): 83 - 89.
[Abstract] [PDF]


Home page
Arch SurgHome page
E. Ernst
St John's Wort Supplements Endanger the Success of Organ Transplantation
Arch Surg, March 1, 2002; 137(3): 316 - 319.
[Abstract] [Full Text] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 2000 by Harvey Whitney Books Company.